Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)

L. Nanetti, M. Kearney, S. Boesch, L. Stovickova, JD. Ortigoza-Escobar, A. Macaya, D. Gomez-Andres, E. Roze, MJ. Molnar, NI. Wolf, A. Darling, G. Vasco, E. Bertini, E. Indelicato, D. Neubauer, TB. Haack, JC. Sagi, FR. Danti, D. Sival, G. Zanni,...

. 2024 ; 45 (3) : 1007-1016. [pub] 20231019

Language English Country Italy

Document type Journal Article

Grant support
ERN-RND Framework Partnership Agreement 2022-23 European Union

E-resources Online Full text

NLK ProQuest Central from 2000-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-02-01 to 1 year ago
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago
Family Health Database (ProQuest) from 2000-01-01 to 1 year ago
Psychology Database (ProQuest) from 2000-01-01 to 1 year ago

BACKGROUND: Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions. AIM: To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND). METHODS: Members of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network. RESULTS: Twenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice. CONCLUSIONS: This survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.

Amsterdam Leukodystrophy Center Department of Child Neurology Emma's Children's Hospital Vrije Universiteit Amsterdam Amsterdam Neuroscience Cellular and Molecular Mechanisms Amsterdam The Netherlands

APHP Université Paris Cité INSERM UMR1141 Hôpital Robert Debré Service de Neuropédiatrie Centre de Reference LEUKOFRANCE Paris France

Center for Rare Movement Disorders Department of Neurology Innsbruck Austria

Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics University Hospital Tübingen Tübingen Germany

Centre of Hereditary Ataxias Department of Pediatric Neurology 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic

Department of Neurology and Hertie Institute for Clinical Brain Research University of Tübingen and German Center for Neurodegenerative Diseases Tübingen Germany

Department of Paediatric Neurology Beatrix Children's Hospital University Medical Center Groningen University of Groningen Groningen The Netherlands

Department of Paediatrics Semmelweis University Dept of Genetics Cell and Immunobiology Semmelweis University Budapest Hungary

Department of Pediatric Neurosciences Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy

Department of Rehabilitation Medicine Emma Children's Hospital Amsterdam Vrije Universiteit Amsterdam Amsterdam Movement Science Rehabilitation and Development Amsterdam The Netherlands

Donders Institute for Brain Cognition and Behaviour Radboud University Medical Center Nijmegen the Netherlands

Institute of Genomic Medicine and Rare Disorders Semmelweis University Budapest Hungary

Institute of Medical Genetics and Applied Genomics University of Tübingen Tübingen Germany

Osservatorio Malattie Rare Rarelab S R L Rome Italy

Patient Advocate at the European Reference Network Representing Individuals With Ataxia and Neurology Research Fellow at the National Ataxia Centre Tallaght University Dublin Ireland

Pediatric Neurology Department Institut de Recerca Hospital Sant Joan de Déu Barcelona Barcelona Spain

Pediatric Neurology Vall d'Hebron Institut de Recerca Hospital Universitari Vall d'Hebron Vall d'Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona Bellaterra Spain

Research Unit of Neurorehabilitation IRCCS Bambino Gesù Children's Research Hospital Rome Italy

Sorbonne University INSERM CNRS Paris Brain Institute APHP Salpêtrière Hospital Paris France

Tartu University Hospital Children's Clinic Department of Pediatrics and Neurology Tartu Estonia

UMCL Children's Hospital Ljubljana and University of Ljubljana Ljubljana Slovenia

Unit of Medical Genetics and Neurogenetics Fondazione IRCCS Istituto Neurologico Carlo Besta Via Celoria 11 20133 Milan Italy

Unit of Neuromuscular and Neurodegenerative Disease IRCCS Bambino Gesù Children's Research Hospital Rome Italy

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006998
003      
CZ-PrNML
005      
20240423155635.0
007      
ta
008      
240412s2024 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10072-023-07101-3 $2 doi
035    __
$a (PubMed)37853291
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Nanetti, Lorenzo $u Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy
245    10
$a Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND) / $c L. Nanetti, M. Kearney, S. Boesch, L. Stovickova, JD. Ortigoza-Escobar, A. Macaya, D. Gomez-Andres, E. Roze, MJ. Molnar, NI. Wolf, A. Darling, G. Vasco, E. Bertini, E. Indelicato, D. Neubauer, TB. Haack, JC. Sagi, FR. Danti, D. Sival, G. Zanni, A. Kolk, O. Boespflug-Tanguy, L. Schols, B. van de Warrenburg, M. Vidailhet, MA. Willemsen, AI. Buizer, E. Orzes, S. Ripp, C. Reinhard, I. Moroni, C. Mariotti, ERN-RND Working Group for Management of Transition
520    9_
$a BACKGROUND: Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions. AIM: To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND). METHODS: Members of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network. RESULTS: Twenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice. CONCLUSIONS: This survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.
650    _2
$a dospělí $7 D000328
650    _2
$a mladiství $7 D000293
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a průzkumy a dotazníky $7 D011795
650    12
$a poskytování zdravotní péče $7 D003695
650    12
$a nemoci nervového systému $x diagnóza $x terapie $7 D009422
650    _2
$a vzácné nemoci $x diagnóza $x terapie $7 D035583
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kearney, Mary $u Patient Advocate at the European Reference Network Representing Individuals With Ataxia, and Neurology Research Fellow at the National Ataxia Centre, Tallaght University, Dublin, Ireland
700    1_
$a Boesch, Sylvia $u Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria
700    1_
$a Stovickova, Lucie $u Centre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
700    1_
$a Ortigoza-Escobar, Juan Darío $u Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
700    1_
$a Macaya, Alfons $u Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain
700    1_
$a Gomez-Andres, David $u Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain
700    1_
$a Roze, Emmanuel $u Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France
700    1_
$a Molnar, Maria-Judit $u Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary
700    1_
$a Wolf, Nicole I $u Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma's Children's Hospital, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands
700    1_
$a Darling, Alejandra $u Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
700    1_
$a Vasco, Gessica $u Research Unit of Neurorehabilitation, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
700    1_
$a Bertini, Enrico $u Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
700    1_
$a Indelicato, Elisabetta $u Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria
700    1_
$a Neubauer, David $u UMCL, Children's Hospital Ljubljana and University of Ljubljana, Ljubljana, Slovenia
700    1_
$a Haack, Tobias B $u Institute of Medical Genetics and Applied Genomics University of Tübingen, Tübingen, Germany
700    1_
$a Sagi, Judit C $u Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary $u Department of Paediatrics, Semmelweis University, Dept. of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
700    1_
$a Danti, Federica R $u Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
700    1_
$a Sival, Deborah $u Department of Paediatric Neurology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
700    1_
$a Zanni, Ginevra $u Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
700    1_
$a Kolk, Anneli $u Tartu University Hospital Children's Clinic, Department of Pediatrics and Neurology, Tartu, Estonia
700    1_
$a Boespflug-Tanguy, Odile $u APHP, Université Paris Cité, INSERM UMR1141, Hôpital Robert Debré, Service de Neuropédiatrie, Centre de Reference LEUKOFRANCE, Paris, France
700    1_
$a Schols, Ludger $u Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany
700    1_
$a van de Warrenburg, Bart $u Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Vidailhet, Marie $u Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France
700    1_
$a Willemsen, Michèl A $u Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands
700    1_
$a Buizer, Annemieke I $u Department of Rehabilitation Medicine, Emma Children's Hospital, Amsterdam, Vrije Universiteit, Amsterdam, Amsterdam Movement Science, Rehabilitation and Development, Amsterdam, The Netherlands
700    1_
$a Orzes, Enrico $u Osservatorio Malattie Rare - Rarelab S.R.L., Rome, Italy
700    1_
$a Ripp, Sophie $u Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
700    1_
$a Reinhard, Carola $u Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
700    1_
$a Moroni, Isabella $u Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
700    1_
$a Mariotti, Caterina $u Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy. caterina.mariotti@istituto-besta.it $1 https://orcid.org/0000000324053564
710    2_
$a ERN-RND Working Group for Management of Transition
773    0_
$w MED00005781 $t Neurological sciences $x 1590-3478 $g Roč. 45, č. 3 (2024), s. 1007-1016
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37853291 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155632 $b ABA008
999    __
$a ok $b bmc $g 2081161 $s 1216765
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 45 $c 3 $d 1007-1016 $e 20231019 $i 1590-3478 $m Neurological sciences $n Neurol Sci $x MED00005781
GRA    __
$a ERN-RND Framework Partnership Agreement 2022-23 $p European Union
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...